Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2M Sell
101,766
-1,319
-1% -$154K 8.26% 1
2026
Q1
$12.5M Sell
103,085
-3,299
-3% -$381K 8.41% 1
2025
Q4
$11.3M Sell
106,384
-1,764
-2% -$166K 7.77% 1
2025
Q3
$9.16M Sell
108,148
-514
-0.5% -$42.3K 6.55% 2
2025
Q2
$8.69M Buy
108,662
+1,107
+1% +$88K 6.54% 2
2025
Q1
$9.74M Buy
107,555
+15,223
+16% +$1.42M 7.1% 1
2024
Q4
$9.25M Buy
+92,332
New +$9.52M 6.77% 2

Other funds holding MRK

Clark & Stuart Inc's MRK Position: Q2 2026 in Review

Clark & Stuart Inc reduced its Merck (MRK) stake by 1.3% in Q2 2026, selling an estimated $154K and leaving 101,766 shares worth $13.2M. The position accounts for 8.26% of the portfolio, ranked #1.

Clark & Stuart Inc first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,038 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Clark & Stuart Inc held 101,766 shares of Merck worth $13.2M as of Q2 2026.
  • Clark & Stuart Inc sold 1,319 Merck shares in Q2 2026, an estimated $154K.
  • Merck made up 8.26% of Clark & Stuart Inc's portfolio in Q2 2026, its #1 holding.
  • Clark & Stuart Inc first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,038 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Clark & Stuart Inc's 13F filing for Q2 2026, filed 14 Jul 2026.